Physician

Amanda Zeta De La Paz, M.D.

According to 2025 Medicare claims, Amanda Paz, M.D. (NPI: 1215236484) practices geriatric medicine in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is TEMPLE FACULTY PRACTICE PLAN INC (NPI: 1053893099; TIN: 831002191) and primary practice location at 19031-1802. Paz is affiliated with the Temple Care, Inc (ACO ID: D0012), participating under the REACH model.

Paz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 175 traditional Medicare patients, billed 697 HCPCS/CPT codes, and received $62,703 in Medicare payments. The top billing code was 99306 (Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more). Part D data shows 8,176 prescription claims across 259 beneficiaries totaling $689,407 in drug costs, led by Tetrabenazine (Tetrabenazine). DME data shows 79 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $25,607 and ending at $62,703. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $20,861 to $689,407. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $167 to $6,323.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	77	362	$25,607
2016	156	665	$45,230
2017	180	683	$49,812
2018	225	927	$70,082
2019	238	640	$47,500
2020	175	568	$51,392
2021	159	681	$61,625
2022	135	473	$44,399
2023	139	583	$56,522
2024	175	697	$62,703

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	100	406	$20,861
2016	120	693	$44,537
2017	116	747	$46,810
2018	127	872	$46,839
2019	121	911	$54,348
2020	138	1,261	$84,609
2021	155	1,561	$101,347
2022	208	4,591	$267,022
2023	253	8,691	$550,606
2024	259	8,176	$689,407

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	16	$667
2022	N/R	N/R	N/R
2023	N/R	28	$796
2024	N/R	79	$1,746

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99306	Initial nursing facility care with high level of medical decision making, per day, if using time, 50 minutes or more	33	36	$148
99310	Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes	41	104	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	45	81	$86
99309	Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes	59	207	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	36	45	$64

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tetrabenazine	Tetrabenazine	14	364	$142,318
Eliquis	Apixaban	225	4,248	$88,205
Trulicity	Dulaglutide	29	1,012	$35,827
Prolia	Denosumab	15	2,700	$27,827
Xarelto	Rivaroxaban	52	1,101	$21,489

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	33	$1,308
K0002	Standard hemi (low seat) wheelchair	Y	N/R	14	$320
K0195	Elevating leg rests, pair (for use with capped rental wheelchair base)	Y	N/R	15	$92
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	N	N/R	17	$26

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Amanda Zeta De La Paz, M.D.?

Tedicare shows public-source Medicare data for Amanda Zeta De La Paz, M.D. (NPI 1215236484), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amanda Zeta De La Paz, M.D. have ACO affiliation data?

Amanda Zeta De La Paz, M.D. is shown with ACO affiliation data for Temple Care, Inc (REACH, ACO ID D0012).

What billing organization is linked to Amanda Zeta De La Paz, M.D.?

Amanda Zeta De La Paz, M.D. is linked to TEMPLE FACULTY PRACTICE PLAN INC (billing NPI 1053893099) in the available physician profile data.

Does Amanda Zeta De La Paz, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.